Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleContinuing Education

18F-FES Whole-Body Imaging Protocol for Evaluating Tumor Estrogen Receptor Status in Patients with Recurrent or Metastatic Breast Cancer

Barbara J. Grabher
Journal of Nuclear Medicine Technology September 2023, 51 (3) 188-193; DOI: https://doi.org/10.2967/jnmt.122.265272
Barbara J. Grabher
Grabher Consulting & Specialty Services, Forest Hill, Maryland
CNMT, RT(N), NCT FSNMMI-TS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 51 no. 3 188-193
DOI 
https://doi.org/10.2967/jnmt.122.265272
PubMed 
37433673

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Received for publication November 30, 2022
  • Revision received April 25, 2023
  • Published online September 5, 2023.

Article Versions

  • previous version (July 11, 2023 - 10:22).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2023 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Barbara J. Grabher, CNMT, RT(N), NCT FSNMMI-TS
  1. Grabher Consulting & Specialty Services, Forest Hill, Maryland
  1. For correspondence or reprints, contact Barbara J. Grabher (barbara.grabher{at}gmail.com).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 3 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Artificial Intelligence for Drug Discovery: An Update and Future Prospects
    Harrison J. Howell, Jeremy P. McGale, Aurélie Choucair, Dorsa Shirini, Nicolas Aide, Michael A. Postow, Lucy Wang, Mickael Tordjman, Egesta Lopci, Augustin Lecler, Stéphane Champiat, Delphine L. Chen, Désirée Deandreis, Laurent Dercle
    Seminars in Nuclear Medicine 2025 55 3
  • Estrogen Receptor–targeted PET Imaging for Breast Cancer
    Wenhui Zhou, Benjamin L. Franc, Wendy B. DeMartini, Eric L. Rosen
    Radiology 2024 312 2
  • FAP-Targeted SPECT/CT and PET/CT Imaging for Breast Cancer Patients
    Jeremy McGale, Sakshi Khurana, Harrison Howell, Abanoub Nakhla, Tina Roa, Parth Doshi, Dorsa Shirini, Alice Huang, Phuong Duong, Philipp Backhaus, Matthew Liao, Harleen Kaur, Amelia McNiven Fontani, Isabella Hung, Neeta Pandit-Taskar, Uwe Haberkorn, Amit Gulati, Asmâa Naim, Mathieu Sinigaglia, Maria Bebawy, Antoine Girard, Romain-David Seban, Laurent Dercle
    Clinical Nuclear Medicine 2025 50 3

Article usage

Article usage: July 2023 to April 2025

AbstractFullPdf
Jul 2023629335
Aug 2023618018
Sep 202319918351
Oct 2023155238221
Nov 202314021258
Dec 2023439138
Jan 2024519534
Feb 2024557244
Mar 2024405647
Apr 2024318030
May 20243110131
Jun 2024329322
Jul 2024348528
Aug 2024338437
Sep 2024377940
Oct 20243212337
Nov 2024299044
Dec 20241510017
Jan 2025268635
Feb 20253421039
Mar 20251523542
Apr 20253022155
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 51 (3)
Journal of Nuclear Medicine Technology
Vol. 51, Issue 3
September 1, 2023
  • Table of Contents
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
18F-FES Whole-Body Imaging Protocol for Evaluating Tumor Estrogen Receptor Status in Patients with Recurrent or Metastatic Breast Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
18F-FES Whole-Body Imaging Protocol for Evaluating Tumor Estrogen Receptor Status in Patients with Recurrent or Metastatic Breast Cancer
Barbara J. Grabher
Journal of Nuclear Medicine Technology Sep 2023, 51 (3) 188-193; DOI: 10.2967/jnmt.122.265272

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
18F-FES Whole-Body Imaging Protocol for Evaluating Tumor Estrogen Receptor Status in Patients with Recurrent or Metastatic Breast Cancer
Barbara J. Grabher
Journal of Nuclear Medicine Technology Sep 2023, 51 (3) 188-193; DOI: 10.2967/jnmt.122.265272
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MECHANISM OF ACTION, PHARMACODYNAMICS, AND PHARMACOKINETICS
    • PATIENT SELECTION
    • APPROPRIATE-USE CRITERIA FOR ER-TARGETED PET
    • CLINICAL INDICATION AND LIMITATIONS OF USE
    • PATIENT PREPARATION
    • DOSE AND ADMINISTRATION
    • ACQUISITION AND PROCESSING PARAMETERS
    • 18F-FES TRACER DISTRIBUTION PATTERNS
    • IMAGE INTERPRETATION
    • WARNINGS, PRECAUTIONS, AND ADVERSE REACTIONS
    • USE IN SPECIAL PATIENT POPULATIONS
    • BENEFITS OF 18F-FES ER IMAGING
    • SUPPORT WITH 18F-FES ACCESS
    • CONCLUSION
    • DISCLOSURE
    • ACKNOWLEDGMENTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The Gathering
  • Google Scholar

More in this TOC Section

  • Illuminating the Hidden: Standardizing Cardiac MIBG Imaging for Sympathetic Dysfunction
  • PET/CT Case Series: Unmasking the Mystery of Cardiac Sarcoidosis
  • Delivery Methods of Radiopharmaceuticals: Exploring Global Strategies to Minimize Occupational Radiation Exposure
Show more Continuing Education

Similar Articles

Keywords

  • breast cancer
  • estrogen receptor imaging
  • 18F-fluoroestradiol
  • Cerianna
  • patient outcomes
SNMMI

© 2025 SNMMI

Powered by HighWire